Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma, Newly Diagnosed”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT05552222
What this trial is testing

Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 1,590
Large-scale testing (Phase 3)Study completedNCT02112175
What this trial is testing

Lenalidomide vs Placebo Maintenance Therapy Following Melphalan Prednisone Velcade® Induction Therapy in NDMM

Who this might be right for
Multiple Myeloma
Celgene 46
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07029776
What this trial is testing

MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple Myeloma

Who this might be right for
Multiple Myeloma (MM)
University of Arkansas 50
Testing effectiveness (Phase 2)Study completedNCT01335685
What this trial is testing

Study of Oral Ixazomib in Combination With Melphalan and Prednisone in Participants With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Millennium Pharmaceuticals, Inc. 61
Early research (Phase 1)Study completedNCT01660750
What this trial is testing

A Safety Study of Carfilzomib, Cyclophosphamide & Dexamethasone Prior to ASCT in Patients With Newly Diagnosed Myeloma

Who this might be right for
Multiple Myeloma
Criterium, Inc. 29
Testing effectiveness (Phase 2)Looking for participantsNCT07099391
What this trial is testing

Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 65
Testing effectiveness (Phase 2)Active Not RecruitingNCT03500445
What this trial is testing

Daratumumab, Carfilzomib, Lenalidomide and Low Dose Dexamethasone (DKRd) in Newly Diagnosed, Multiple Myeloma

Who this might be right for
MyelomaMultiple Myeloma
University of Chicago 75
Large-scale testing (Phase 3)Study completedNCT00367185
What this trial is testing

Treatment of Newly Diagnosed Elderly Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
University Hospital, Lille 500
Testing effectiveness (Phase 2)Study completedNCT00151203
What this trial is testing

Phase II Study of Biaxin, Revlimid, and Dexamethasone for Untreated Multiple Myeloma

Who this might be right for
Multiple Myeloma
Weill Medical College of Cornell University 50
Not applicableUnknownNCT03122327
What this trial is testing

CGA in Newly-diagnosed Elderly MM Patients: a Multi-center, Prospective, Non-interventional Study.

Who this might be right for
Multiple MyelomaComprehensive Geriatric Assessment
Peking Union Medical College Hospital 200
Post-approval studies (Phase 4)Ended earlyNCT02773550
What this trial is testing

Treatment With a Scheme With Low Doses of Bortezomib / Melphalan / Prednisone (MPV) in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Basque Health Service 24
Testing effectiveness (Phase 2)Study completedNCT02843074
What this trial is testing

Elotuzumab, Lenalidomide and Dexamethasone in Treatment of Transplant-Eligible Newly Diagnosed Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
SCRI Development Innovations, LLC 53
Early research (Phase 1)Study completedNCT02513186
What this trial is testing

Study of Isatuximab Combined With Bortezomib + Cyclophosphamide + Dexamethasone (VCD) and Bortezomib + Lenalidomide + Dexamethasone (VRD) in Newly Diagnosed Multiple Myeloma (MM) Non Eligible for Transplant or No Intent for Immediate Transplantation

Who this might be right for
Plasma Cell Myeloma
Sanofi 90
Testing effectiveness (Phase 2)Study completedNCT02204241
What this trial is testing

Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
European Myeloma Network B.V. 36
Large-scale testing (Phase 3)Active Not RecruitingNCT04096066
What this trial is testing

A Trial That Compare Two Treatments in Newly Diagnosed Myeloma Patients Not Eligible for Transplant

Who this might be right for
Multiple MyelomaNew Diagnosis Tumor
Fondazione EMN Italy Onlus 84
Early research (Phase 1)Not Yet RecruitingNCT05181501
What this trial is testing

Fully Human BCMA CAR-T (CT103A) in Patients With Newly Diagnosed High-risk Multiple Myeloma (FUMANBA-2)

Who this might be right for
Multiple Myeloma
Nanjing IASO Biotechnology Co., Ltd. 20
Large-scale testing (Phase 3)Study completedNCT00376883
What this trial is testing

Pamidronate Prophylaxis in Multiple Myeloma 30 mg/Month Versus 90 mg/Month

Who this might be right for
Multiple Myeloma
Nordic Myeloma Study Group 500
Not applicableLooking for participantsNCT06099912
What this trial is testing

Individualized Dynamic Frailty-tailored Therapy (DynaFiT) in Elderly Patients With NDMM

Who this might be right for
Multiple MyelomaFrailty
FengYan Jin 131
Large-scale testing (Phase 3)Active Not RecruitingNCT00602641
What this trial is testing

Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
National Cancer Institute (NCI) 306
Large-scale testing (Phase 3)Study completedNCT00344422
What this trial is testing

Vincristine, DOXIL (Doxorubicin HCl Liposome Injection) and Dexamethasone vs. Vincristine, Doxorubicin, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple MyelomaMyelomaM-Protein+1 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 198
Next Page